The worldwide chronic heart failure therapeutics market is experiencing a period of substantial growth. This trend can be linked to the rising prevalence of chronic heart failure globally, coupled with advancements in treatment options. The market is marked by a diverse range of therapeutics, addressing different aspects of the disease. Leading pla